About Us

The Life Science Industry’s Largest Data and Business Process Platform for Therapy Commercialization and Access

IntegriChain is on a mission… to help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.

Proven Success at Making Life Sciences Data Actionable

More than a decade ago, IntegriChain pioneered channel data aggregation, data stewardship and governance as well as advanced analytics. Enhanced by data science, our solutions make specialty pharmacy, retail pharmacy, distributor and patient services data actionable.
With the help of private equity support, IntegriChain has expanded our business to include managed services and an application platform across key related disciplines including government pricing, rebate management and gross to net. We recently joined forces with Cumberland Life Sciences, a leading provider of contracts and pricing related managed services, advisory services, and system integration services.

IntegriChain now has the largest managed services platform in the industry, supporting more than 150 manufacturer customers every day. We also have grown team of world-class commercialization and market access experts to more than 370. Today, our global IntegriChain team is uniquely positioned to address critical therapy access challenges throughout the drug commercialization life cycle, ensuring that patients have access to their life-saving and life-changing medicines as needed and minimizing the chances that they forego therapy.

Our Vision

“IntegriChain continues to have a laser-like focus on helping patients get and stay on therapies they need. We do this with our relentless, customer-centric focus and innovation that enables life sciences manufacturers to quickly identify and eliminate all types of access-related obstacles throughout the brand life cycle, from pre-launch through growth.”

Kevin Leininger
Co-Founder and CEO


Trusted by World-Class Life Sciences Innovators of all Size

From improving launch readiness to enabling regulatory compliance and access to government programs as well as optimizing distribution and patient access strategies and programs, IntegriChain plays a vital role in enabling our customers to make better and faster payer, channel and patient support decisions. In fact, more than 220 life science manufacturers— ranging from pre-commercial manufacturers to Big Pharma and including 20 of the Top-20 companies rely on IntegriChain’s world-class data, managed and professional services. Together, we have participated in 71% of product launches over the past 2 years including 35 first launches. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm.

We are passionate about our customers’ mission – improving the lives of patients – and view it as our own.

user conference

Update

Access Insights Conference

Our 2020 conference is cancelled. Watch for updates on fall regional events and our 2021 conference.
Read Cancellation Statement

 

join the integrichain team

Join Our Team!

We’re always looking for the best and brightest to join our tech team. See available careers today!

View Opportunities

The Power of IntegriChainers

We are a collective force of tech innovators and problem solvers with a laser focus on helping patients start therapy faster and stay on therapy longer. Learn more about careers at IntegriChain.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand